Related Experiment Video
Updated: Oct 18, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest
G S Wu1, T F Burns, E R McDonald
1Department of Medicine, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine Philadelphia 19104, USA.
Abstract:
The TRAIL death receptor KILLER/DR5 is induced by DNA damaging agents in wild-type p53-expressing cells. Here we show that, unlike the p53-target CDK-inhibitor p21WAF1/CIP1, the TRAIL death receptor KILLER/DR5 is only induced in cells undergoing p53-dependent apoptosis and not cell cycle arrest. Thus GM glioblastoma cells carrying an inducible MMTV-driven p53 gene undergo cell cycle arrest and upregulate p21 but not KILLER/DR5 expression upon dexamethasone exposure. WI38 normal lung fibroblasts undergoing cell cycle arrest in response to ionizing irradiation also induce p21 but not KILLER/DR5 gene expression. KILLER/DR5 upregulation is also deficient in irradiated lymphoblastoid cells derived from patients with Ataxia Teleangiectasia suggesting a role for the ATM-p53 pathway in regulating KILLER/DR5 expression after DNA damage. Inhibition of transcription by Actinomycin D blocks both KILLER/DR5 and p21 induction in cells undergoing p53-dependent apoptosis. Our results suggest that the p53-dependent transcriptional induction of KILLER/DR5 death receptor is restricted to cells undergoing apoptosis and not cells undergoing exclusively p53-dependent G1 arrest.
Insights
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor, KILLER/DR5, is upregulated during p53-dependent apoptosis but not cell cycle arrest. This suggests a specific role for KILLER/DR5 in apoptosis following DNA damage.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The TRAIL death receptor, KILLER/DR5, is known to be induced by DNA-damaging agents in p53-expressing cells.
- p53 is a critical tumor suppressor protein that regulates cell cycle arrest and apoptosis in response to DNA damage.
Purpose of the Study:
- To investigate the differential regulation of KILLER/DR5 and p21WAF1/CIP1 expression by the p53 pathway.
- To determine whether KILLER/DR5 induction is specific to apoptosis or also occurs during cell cycle arrest.
Main Methods:
- Utilized inducible p53 expression systems in GM glioblastoma cells and normal lung fibroblasts (WI38).
- Exposed cells to dexamethasone or ionizing irradiation to induce DNA damage and p53 activation.
- Analyzed gene expression of KILLER/DR5 and p21WAF1/CIP1 using quantitative methods.
- Investigated the role of the ATM-p53 pathway in KILLER/DR5 regulation using cells from Ataxia Telangiectasia patients.
- Assessed the impact of transcriptional inhibition (Actinomycin D) on KILLER/DR5 and p21 induction.
Main Results:
- GM glioblastoma cells with inducible p53 arrested the cell cycle and upregulated p21 but not KILLER/DR5 upon dexamethasone treatment.
- WI38 fibroblasts undergoing irradiation-induced cell cycle arrest also upregulated p21 but not KILLER/DR5.
- KILLER/DR5 upregulation was impaired in irradiated lymphoblastoid cells from Ataxia Telangiectasia patients, indicating a role for the ATM-p53 pathway.
- Actinomycin D blocked both KILLER/DR5 and p21 induction in cells undergoing p53-dependent apoptosis.
Conclusions:
- The p53-dependent transcriptional induction of the KILLER/DR5 death receptor is specifically linked to apoptosis.
- KILLER/DR5 is not induced in cells undergoing exclusively p53-dependent G1 cell cycle arrest.
- The findings highlight a distinct regulatory mechanism for KILLER/DR5 compared to other p53 target genes like p21.
More Related Videos
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle